S H Azarmi

660 total citations
11 papers, 509 citations indexed

About

S H Azarmi is a scholar working on Pharmaceutical Science, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S H Azarmi has authored 11 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S H Azarmi's work include Advanced Drug Delivery Systems (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Advancements in Transdermal Drug Delivery (2 papers). S H Azarmi is often cited by papers focused on Advanced Drug Delivery Systems (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Advancements in Transdermal Drug Delivery (2 papers). S H Azarmi collaborates with scholars based in Iran, Canada and United Kingdom. S H Azarmi's co-authors include Ali Nokhodchi, Mohammad Reza Siahi-Shadbad, Mitra Jelvehgari, Gary P. Martin, Hongbin Chen, William J.J. Finlay, Xutang Tao, Raimar Löbenberg, Wilson Roa and Zhicheng Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and BioMed Research International.

In The Last Decade

S H Azarmi

10 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S H Azarmi Iran 7 297 127 113 72 70 11 509
Kifayat Ullah Shah Pakistan 13 268 0.9× 98 0.8× 149 1.3× 78 1.1× 64 0.9× 41 532
Nagia Afifi Egypt 7 231 0.8× 73 0.6× 81 0.7× 98 1.4× 29 0.4× 10 439
S. Saisivam India 12 376 1.3× 82 0.6× 64 0.6× 50 0.7× 58 0.8× 20 533
Mohamed S. El-Samaligy Egypt 9 299 1.0× 96 0.8× 95 0.8× 112 1.6× 48 0.7× 11 541
Shadeed Gad Egypt 15 408 1.4× 51 0.4× 90 0.8× 127 1.8× 82 1.2× 71 624
Biswadip Sinha Germany 8 375 1.3× 101 0.8× 126 1.1× 92 1.3× 60 0.9× 9 603
Ahmed N. Allam Egypt 16 225 0.8× 67 0.5× 130 1.2× 160 2.2× 59 0.8× 24 574
Solmaz Ghaffari Iran 15 241 0.8× 74 0.6× 118 1.0× 151 2.1× 77 1.1× 24 560
Mariana Rillo Sato Brazil 14 188 0.6× 107 0.8× 115 1.0× 124 1.7× 50 0.7× 31 540
Edina Pallagi Hungary 19 353 1.2× 107 0.8× 144 1.3× 177 2.5× 74 1.1× 28 708

Countries citing papers authored by S H Azarmi

Since Specialization
Citations

This map shows the geographic impact of S H Azarmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S H Azarmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S H Azarmi more than expected).

Fields of papers citing papers by S H Azarmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S H Azarmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S H Azarmi. The network helps show where S H Azarmi may publish in the future.

Co-authorship network of co-authors of S H Azarmi

This figure shows the co-authorship network connecting the top 25 collaborators of S H Azarmi. A scholar is included among the top collaborators of S H Azarmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S H Azarmi. S H Azarmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Azarmi, S H, et al.. (2013). Preparation and In vitro Evaluation of Naproxen Suppositories.. PubMed. 75(2). 143–8. 5 indexed citations
2.
Varshosaz, Jaleh, Solmaz Ghaffari, Abbas Jafarian‐Dehkordi, et al.. (2013). Biodistribution of Amikacin Solid Lipid Nanoparticles after Pulmonary Delivery. BioMed Research International. 2013. 1–8. 66 indexed citations
3.
Shokri, Javad, et al.. (2012). Effects of various penetration enhancers on percutaneous absorption of piroxicam from emulgels.. PubMed. 7(4). 225–34. 24 indexed citations
4.
Mozafari, M. R., et al.. (2009). Role of nanocarrier systems in cancer nanotherapy. Journal of Liposome Research. 19(4). 310–321. 64 indexed citations
5.
Mohammadi, Ghobad, et al.. (2009). The effect of inorganic cations Ca2+ and Al3+ on the release rate of propranolol hydrochloride from sodium carboxymethylcellulose matrices. SHILAP Revista de lepidopterología. 17(2). 131–138. 8 indexed citations
6.
Barzegar-Jalali, Mohammad, et al.. (2007). STUDY ON THE RELEASE OF ACETAZOLAMIDE FROM MATRICES CONTAINING TRAGACANTH AND ACACIA GUMS. 21–28. 3 indexed citations
7.
Barzegar-Jalali, Mohammad, et al.. (2007). THE EFFECT OF AL3+ ON THE PROPRANOLOL HYDROCHLORIDE RELEASE FROM POLYANIONIC POLYMER MATRICES. 7–17. 1 indexed citations
8.
Azarmi, S H, Xutang Tao, Hongbin Chen, et al.. (2006). Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. International Journal of Pharmaceutics. 319(1-2). 155–161. 134 indexed citations
9.
Shokri, Javad, et al.. (2006). ENHANCEMENT OF OXAZEPAM DISSOLUTION RATE USING OXAZEPAM- SURFACTANT SOLID DISPERSIONS. 35–45. 4 indexed citations
10.
Jelvehgari, Mitra, Mohammad Reza Siahi-Shadbad, S H Azarmi, Gary P. Martin, & Ali Nokhodchi. (2005). The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. International Journal of Pharmaceutics. 308(1-2). 124–132. 144 indexed citations
11.
Azarmi, S H, et al.. (2002). Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices. International Journal of Pharmaceutics. 246(1-2). 171–177. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026